Accenture Stock In Buy Zone, Joins Elite Club With 96 Composite Rating

The IBD SmartSelect Composite Rating for Accenture (ACN) increased from 94 to 96 Tuesday. Is Accenture stock on your watchlist?


The new rating is a sign that Accenture stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria.

Is Accenture Stock A Buy?

Accenture stock is trading within the buy zone from a 294.60 entry from a flat base.

Looking For The Best Stocks To Buy And Watch? Try These Screens


Accenture stock has an 84 EPS Rating, meaning the consulting firm’s recent quarterly and annual earnings growth is outpacing 84% of all stocks.

Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.

The Dublin, Ireland-domiciled company reported 26% earnings growth for Q3. That marks two straight quarters of rising EPS growth. Sales growth increased 21%, up from 8% in the prior quarter. That marks three consecutive reports with rising growth.

Accenture stock earns the No. 4 rank among its peers in the Computer-Technical Services industry group. Endava (DAVA) is the top-ranked stock within the group.


Find The Best Stocks To Buy Using IBD’s Proprietary Watchlists

MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

IBD Stock Rating Upgrades: Rising Relative Strength

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button